Quantcast

Latest biotechnology Stories

2014-06-23 23:06:59

GrandViewResearch.com has announced the addition of "Global Stem Cells Market Analysis And Segment Forecasts To 2020" Market Research report to their Database. View Complete Report - http://www.grandviewresearch.com/industry-analysis/stem-cells-market. San Francisco, California (PRWEB) June 23, 2014 The global market for stem cells is expected to reach USD 170.15 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of chronic diseases such...

2014-06-23 23:02:46

The increasing number of private hospitals, the automation of industrial manufacturing, and increased monitoring in agricultural and environmental sectors are driving the markets for assembly lines for medical devices, dispensing robots, and biosensors, respectively. http://www.micromarketmonitor.com/market-report/assembly-line-for-medical-devices-reports-4221308681.html. (PRWEB) June 23, 2014 Assembly lines for medical devices are the manufacturing lines on which medical devices can be...

2014-06-23 12:29:40

ANZAC Research Institute uses NextCODE's diagnostics and discovery solutions to mine entire genomes for novel mutations in X-linked Charcot-Marie-Tooth syndrome CAMBRIDGE, Mass., June 23, 2014 /PRNewswire/ -- NextCODE Health today announced that a team at the ANZAC Research Institute in Sydney, Australia have used NextCODE capabilities to home in on novel sequence variants underlying X-linked Charcot-Marie-Tooth syndrome (CMTX). CMTX is a rare and progressively debilitating...

2014-06-23 12:29:24

Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter REDWOOD CITY, Calif., June 23, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an investigational etanercept biosimilar, in rheumatoid arthritis (RA). The Phase 3 trial is a randomized, double-blind, active-control, parallel-group, multicenter, global study in subjects with active RA who have demonstrated an inadequate response to methotrexate....

2014-06-23 12:29:04

AUSTIN, Texas, June 23, 2014 /PRNewswire/ -- XBiotech announced today that Gary Gonzales has joined the Company as Vice President of Clinical Operations. Mr. Gonzales will lead XBiotech's clinical trial team and manage the Company's international clinical operations. Mr. Gonzales joins XBiotech from INC Research where he managed large, global pivotal phase III trials. Mr. Gonzales has B.S. & M.S. degrees in chemistry and biology and also holds a M.B.A. Mr. Gonzales comes to...

2014-06-23 12:28:49

DALLAS, June 23, 2014 /PRNewswire/ -- RnRMarketResearch.com offers Cell Analysis Market by Instruments, Consumables, Application - Global Forecast to 2018 research report in its store that says global cell analysis market is a technology-driven market and is marked by the 'Threat of Obsolescence,' wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and biotechnology companies...

2014-06-23 12:23:37

Biotechnology pioneer will receive the award at the 2014 BIO International Convention, San Diego Convention Center. PHILADELPHIA and SAN DIEGO, June 23, 2014 /PRNewswire-USNewswire/ -- The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have selected Robert S. Langer to receive the 2014 Biotechnology Heritage Award. The award will be presented during the 2014 BIO International Convention, June 23-26 in San Diego, California. "Bob Langer is the...

2014-06-23 08:29:06

Company CEO to present on June 26, 2014, at 10:30am (PDT) JERUSALEM, June 23, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Chief Executive Officer, Nadav Kidron, will present at the 2014 BIO International Convention. This year's global event for biotechnology will take place on June 23-26 at the San Diego...

2014-06-23 08:28:39

MILFORD, Mass., June 23, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced two presentations at the Nucleic Acid Summit 2014 held June 19-20, 2014 in San Diego. "The research presented continues to expand our understanding of small molecule nucleic acid hybrids (SMNH) and the underlying...

2014-06-23 08:27:50

Phase 1 Clinical Data Highlights Factor IXa as an Excellent Target for Anticoagulation Therapy BASKING RIDGE, N.J., June 23, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of actively controllable aptamer therapeutics for the acute care setting, today announced the publication in the Journal of Thrombosis and Thrombolysis of data from a single escalating-dose Phase 1 clinical trial of the REG2...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related